大摩:维持舜宇(2382.HK)“增持”评级 目标价208港元
摩根士丹利发表研究报告指,舜宇光学科技(2382.HK)5月的出货量数据证实其手机镜头出货量正受逆风影响,但车载镜头及手机镜头模组出货量则似乎超预期,预期镜头出货量将在未来几个月开始稳定。该行维持其“增持”评级,目标价208港元。
该行指,车载镜头5月份出货量按年升160%,虽然是受去年低基数带动,但强劲的增长动能令人印象深刻;年初至今车载镜头出货量按年升92%,远超公司全年指引的按年增长20-25%。另外手机镜头的毛利率表现将成为未来股价的催化剂,又指市场似乎未留意到这个对行业的正面因素。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.